ISONIAZID Drug Patent Profile
✉ Email this page to a colleague
When do Isoniazid patents expire, and what generic alternatives are available?
Isoniazid is a drug marketed by Sandoz, Chartwell Rx, Cmp Pharma Inc, Barr, Duramed Pharms Barr, Epic Pharma Llc, Halsey, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lilly, Mk Labs, Nexgen Pharma Inc, Omnivium Pharms, Panray, Perrigo, Pharmavite, Phoenix Labs Ny, Purepac Pharm, Sun Pharm Industries, Thepharmanetwork Llc, Watson Labs, and Whiteworth Town Plsn. and is included in thirty-four NDAs.
The generic ingredient in ISONIAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isoniazid
A generic version of ISONIAZID was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISONIAZID?
- What are the global sales for ISONIAZID?
- What is Average Wholesale Price for ISONIAZID?
Summary for ISONIAZID
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 34 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 153 |
| Clinical Trials: | 226 |
| Patent Applications: | 4,101 |
| Drug Prices: | Drug price information for ISONIAZID |
| DailyMed Link: | ISONIAZID at DailyMed |
Recent Clinical Trials for ISONIAZID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Freundeskreis Für Internationale Tuberkulosehilfe e.V | Phase 3 |
| Jawaharlal Institute of Postgraduate Medical Education & Research | Phase 3 |
| North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences | Phase 3 |
Pharmacology for ISONIAZID
| Drug Class | Antimycobacterial |
Medical Subject Heading (MeSH) Categories for ISONIAZID
Anatomical Therapeutic Chemical (ATC) Classes for ISONIAZID
US Patents and Regulatory Information for ISONIAZID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | ISONIAZID | isoniazid | TABLET;ORAL | 085784-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | ISONIAZID | isoniazid | TABLET;ORAL | 083633-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Phoenix Labs Ny | ISONIAZID | isoniazid | TABLET;ORAL | 080368-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Thepharmanetwork Llc | ISONIAZID | isoniazid | TABLET;ORAL | 202610-001 | Oct 29, 2014 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Purepac Pharm | ISONIAZID | isoniazid | TABLET;ORAL | 080132-003 | Jul 14, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
